Literature DB >> 20039674

Single domain antibodies are specially suited for quantitative determination of gliadins under denaturing conditions.

Vanina Doña1, Mariela Urrutia, Mariela Bayardo, Vanina Alzogaray, Fernando Alberto Goldbaum, Fernando G Chirdo.   

Abstract

Food intended for celiac patients' consumption must be analyzed for the presence of toxic prolamins using high detectability tests. Though 60% ethanol is the most commonly used solvent for prolamins extraction, 2-mercaptoethanol (2-ME) and guanidinium chloride (GuHCl) can be added to increase protein recovery. However, ethanol and denaturing agents interfere with antigen recognition when conventional antibodies are used. In the present work, a new method for gliadins quantification is shown. The method is based on the selection of llama single domain antibody fragments able to operate under denaturing conditions. Six out of 28 VHH-phages obtained retained their binding capacity in 15% ethanol. Selected clones presented a long CDR3 region containing two additional cysteines that could be responsible for the higher stability. One of the clones (named VHH26) was fully operative in the presence of 15% ethanol, 0.5% 2-ME, and 0.5 M GuHCl. Capture ELISA using VHH26 was able to detect gliadins in samples shown as negatives by conventional ELISA. Therefore, this new strategy appears as an excellent platform for quantitative determination of proteins or any other immunogenic compound, in the presence of denaturing agents, when specific recognition units with high stability are required.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20039674     DOI: 10.1021/jf902973c

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  12 in total

Review 1.  Biotechnological applications of recombinant single-domain antibody fragments.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2011-06-09       Impact factor: 5.328

2.  Llama-derived single domain antibodies specific for Abrus agglutinin.

Authors:  Ellen R Goldman; George P Anderson; Dan Zabetakis; Scott Walper; Jinny L Liu; Rachael Bernstein; Alena Calm; James P Carney; Thomas W O'Brien; Jennifer L Walker; Eric A E Garber
Journal:  Toxins (Basel)       Date:  2011-11-11       Impact factor: 4.546

3.  Production and Characterization of Biotinylated Anti-fenitrothion Nanobodies and Development of Sensitive Fluoroimmunoassay.

Authors:  Zi-Jian Chen; Yi-Feng Zhang; Jia-Lin Chen; Ze-Shan Lin; Min-Fu Wu; Yu-Dong Shen; Lin Luo; Hong Wang; Xiao-Wei Wen; Bruce Hammock; Hong-Tao Lei; Zhen-Lin Xu
Journal:  J Agric Food Chem       Date:  2022-03-25       Impact factor: 5.895

4.  Evaluation of disulfide bond position to enhance the thermal stability of a highly stable single domain antibody.

Authors:  Dan Zabetakis; Mark A Olson; George P Anderson; Patricia M Legler; Ellen R Goldman
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

5.  Conjugation of biotin-coated luminescent quantum dots with single domain antibody-rhizavidin fusions.

Authors:  Jinny L Liu; Scott A Walper; Kendrick B Turner; Audrey Brozozog Lee; Igor L Medintz; Kimihiro Susumu; Eunkeu Oh; Dan Zabetakis; Ellen R Goldman; George P Anderson
Journal:  Biotechnol Rep (Amst)       Date:  2016-03-03

Review 6.  Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.

Authors:  Gualberto Gonzalez-Sapienza; Martín A Rossotti; Sofía Tabares-da Rosa
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

Review 7.  Advances in the Production and Batch Reformatting of Phage Antibody Libraries.

Authors:  Rose H Reader; Robert G Workman; Ben C Maddison; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

8.  Enhanced production of a single domain antibody with an engineered stabilizing extra disulfide bond.

Authors:  Jinny L Liu; Ellen R Goldman; Dan Zabetakis; Scott A Walper; Kendrick B Turner; Lisa C Shriver-Lake; George P Anderson
Journal:  Microb Cell Fact       Date:  2015-10-09       Impact factor: 5.328

9.  Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.

Authors:  Lorena Garaicoechea; Andrea Aguilar; Gabriel I Parra; Marina Bok; Stanislav V Sosnovtsev; Gabriela Canziani; Kim Y Green; Karin Bok; Viviana Parreño
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

10.  Development and evaluation of single domain antibodies for vaccinia and the L1 antigen.

Authors:  Scott A Walper; Jinny L Liu; Daniel Zabetakis; George P Anderson; Ellen R Goldman
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.